Abstract: In a system for setting current capacity of a charging cable for supply of battery power from one electric vehicle to another electric vehicle, a discharge controller is provided in a supply vehicle to discharge a battery of the supply vehicle to supply battery power to a target vehicle. A charge controller is provided in the target vehicle to charge a battery of the target vehicle with battery power supplied from the supply vehicle. A charging cable part electrically connects the supply vehicle and the target vehicle. The discharge controller is configured to perform control so that a discharging current of the charging cable part is set by detecting an allowable charging current of the charging cable part connected to the supply vehicle and comparing the allowable charging current with a predetermined maximum current outputtable from the supply vehicle.

Abstract: A composition and method according to the present invention may be very effectively used to diagnose malignant gastric cancer and predict the prognosis of gastric cancer.

Abstract: The present invention relates to a method for prevention, alleviation, or treatment of cancer patients, especially epithelial mesenchymal transition (EMP)-subtype cancer patients. If PHGDH, SHMT and MTHFD2 inhibitors are co-administered to patients with cancer in which the expression level of a glutaminase (GLS) gene or a protein encoded thereby has increased, 1C metabolism is more effectively inhibited such that there is a synergistic effect on the inhibition of cancer cell proliferation in patients with refractory cancer that is difficult to treat because of recurrence, metastasis, and anticancer drug resistance, thereby enabling cancer to be very effectively treated. In addition, the expression level of the GLS gene or protein encoded thereby is measured so that information related to customized treatment methods from initial stages is provided to each patient and the success of treatment can be increased.

Abstract: A composition according to the present invention, when used alone, is capable of inhibiting the growth of anticancer drug-resistant cancer by overcoming anticancer drug resistance or enhancing anticancer drug sensitivity, and when co-administered with an anticancer drug, may be used very effectively for the prevention, alleviation or treatment of various cancers, especially anticancer drug-resistant cancer.

Abstract: A composition according to the present invention is capable of inhibiting the growth of cancer cells and cancer stem cells, and also is capable of very effectively inhibiting the metastasis of cancer cells to other tissues. Thus, the composition may be very effectively used not only for the prevention, amelioration or treatment of cancer, but also for the inhibition of cancer metastasis.

Abstract: An embodiment charging power filtering method includes receiving a signal instructing whether or not a filtering request is required from an on-board charger, selecting a mode of a plurality of modes for driving a filter based on the signal instructing whether or not the filtering request is required, and charging a battery using the selected mode.

Abstract: An embodiment system includes a mobile charger and a vehicle. The vehicle includes a connection port designed to interface with the mobile charger and a vehicle battery. A vehicle battery management unit is configured to control a current and a voltage of charging and output by detecting a temperature, a current, and a voltage in each module of the vehicle battery. A power conversion unit includes a motor and an inverter and is configured to convert a voltage received at the connection port to a magnitude of voltage that charges the vehicle battery. A charging management unit is coupled to the second battery management unit and the power conversion unit.